ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INM InMed Pharmaceuticals Inc

0.2279
-0.0241 (-9.56%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 478,442
Bid Price 0.2279
Ask Price 0.325
News -
Day High 0.25

Low
0.227503

52 Week Range

High
2.08

Day Low 0.227503
Share Name Share Symbol Market Stock Type
InMed Pharmaceuticals Inc INM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0241 -9.56% 0.2279 23:00:11
Open Price Low Price High Price Close Price Previous Close
0.245 0.227503 0.25 0.23 0.252
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
922 478,442 US$ 0.2389812 US$ 114,339 - 0.227503 - 2.08
Last Trade Type Quantity Price Currency
18:50:38 25 US$ 0.2279 USD

InMed Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.39M 6.06M - 4.14M -7.95M -1.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

InMed Pharmaceuticals News

Date Time Source News Article
3/05/202414:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202414:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202414:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/27/202414:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
2/22/202412:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/21/202413:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/13/202416:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/09/202411:34Edgar (US Regulatory)Form 8-K - Current report
1/19/202413:33Edgar (US Regulatory)Form 8-K - Current report
1/16/202413:12Edgar (US Regulatory)Form 8-K - Current report
12/26/202312:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/26/202312:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No INM Message Board. Create One! See More Posts on INM Message Board See More Message Board Posts

Historical INM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2910.3370.2275030.2943302886,887-0.0631-21.68%
1 Month0.350.45550.2275030.3239629786,314-0.1221-34.89%
3 Months0.35370.47180.2275030.3413458391,494-0.1258-35.57%
6 Months0.6550.7290.2275030.3766128306,319-0.4271-65.21%
1 Year1.162.080.2275030.8361286604,535-0.9321-80.35%
3 Years2.9519.500.2275032.84758,772-2.72-92.27%
5 Years3.7019.500.2275032.89684,395-3.47-93.84%

InMed Pharmaceuticals Description

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.

Your Recent History

Delayed Upgrade Clock